Protein kinase C and amyloid precursor protein processing in skin fibroblasts from sporadic and familial Alzheimer's disease cases

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1453, Issue 3, 1999, Pages 341-350

  Vestling, Monika ^a   Cedazo Mínguez, Ángel ^a   Adem, Abdu ^a   Wiehager, Birgitta ^a   Racchi, Marco ^b   Lannfelt, Lars ^a   Cowburn, Richard F ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Alzheimer's disease; Amyloid precursor protein; Fibroblast; Presenilin; Protein kinase C

Indexed keywords

AMYLOID PRECURSOR PROTEIN; PROTEIN KINASE C;

AGED; ALZHEIMER DISEASE; ARTICLE; CASE REPORT; CONTROLLED STUDY; ENZYME ACTIVITY; FAMILIAL DISEASE; FEMALE; HUMAN; HUMAN CELL; MALE; MUTATION; PRIORITY JOURNAL; PROTEIN PROCESSING; SKIN FIBROBLAST;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID PRECURSOR PROTEIN SECRETASES; ASPARTIC ENDOPEPTIDASES; CELLS, CULTURED; CULTURE MEDIA; ENDOPEPTIDASES; FEMALE; FIBROBLASTS; HUMANS; MALE; MIDDLE AGED; MUTATION; PROTEIN KINASE C; SKIN; SWEDEN;

EID: 0344507324     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4439(99)00003-4     Document Type: Article

References (48)

1. Glenner G., Wong C.W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120:1984;885-890.
2. Khatoon S., Grundke-Iqbal I., Iqbal K. Brain levels of microtubule-associated protein τ are elevated in Alzheimer's disease: a radio-immuno-slot-blot assay for nanograms of the protein. J. Neurochem. 59:1992;750-753.
3. Esch F.S., Keim P.S., Beattie E.C., Blacher R.W., Culwell A.R., Oltersdorf T., McClure D., Ward P. Cleavage of amyloid β peptide during constitutive processing of its precursor. Science. 248:1990;1122-1124.
4. Sisodia S.S., Koo E.H., Beyreuther K., Unterbeck A., Price D.L. Evidence that β-amyloid protein in Alzheimer's disease is not derived by normal processing. Science. 248:1990;492-495.
5. Golde T.E., Estus S., Younkin L.H., Selkoe D.J., Younkin S.G. Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. Science. 255:1992;728-730.
6. Haass C., Hung A.Y., Schlossmacher M.G., Teplow D.B., Selkoe D.J. β-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms. J. Biol. Chem. 268:1993;3021-3024.
7. Näslund J., Jensen M., Tjernberg L.O., Thyberg J., Terenius L., Nordstedt C. The metabolic pathway generating p3, an Aβ-peptide fragment, is probably non-amyloidogenic. Biophys. Res. Commun. 204:1994;780-787.
8. Estus S., Golde T.E., Kinishita T., Blades D., Lowery D., Eisen M., Usiak M., Qu X., Tabira T., Greenberg B.D., Younkin S.G. Potentially amyloidogenic, carboxyterminal derivatives of the amyloid protein precursor. Science. 255:1992;726-728.
9. Buxbaum J.D., Oishi M., Chen H.I., Pinkas-Kramarski R., Jaffe E.A., Gandy S.E., Greengard P. Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer β/A4 amyloid protein precursor. Proc. Natl. Acad. Sci. U.S.A. 89:1992;10075-10078.
10. Caporaso G.L., Gandy S.E., Buxbaum J.D., Ramabhadran T.V., Greengard P. Protein phosphorylation regulates secretion of Alzheimer β/A4 amyloid precursor protein. Proc. Natl. Acad. Sci. U.S.A. 89:1992;3055-3059.
11. Gillespie S.L., Golde T.E., Younkin S.G. Secretory processing of the Alzheimer amyloid β/A4 protein precursor is increased by protein phosphorylation. Biochem. Biophys. Res. Commun. 187:1992;1285-1290.
12. Nitsch R.M., Slack B.E., Wurtman R.J., Growdon J.H. Release of Alzheimer amyloid precursor derivates stimulated by activation of muscarinic acetylcholine receptors. Science. 258:1992;304-307.
13. Slack B.E., Breu J., Petryniak M.A., Srivastava K., Wurtman R. Tyrosine phosphorylation-dependent stimulation of amyloid precursor protein secretion by the m3 muscarinic acetylcholine receptor. J. Biol. Chem. 270:1995;8337-8344.
14. Xu H., Greengard P., Gandy S. Regulated formation of golgi secretory vesicles containing Alzheimer β-amyloid precursor protein. J. Biol. Chem. 270:1995;23243-23245.
15. LeBlanc A.C., Koutroumanis M., Goodyer C.G. Protein kinase C activation release of secreted amyloid precursor protein without decreasing Aβ production in human primary neuron cultures. J. Neurosci. 18:1998;2907-2913.
16. Buxbaum J.D., Ruefli A.A., Parker C.A., Cypess A.M., Greengard P. Calcium regulates processing of the Alzheimer amyloid protein precursor in a protein kinase C-independent manner. Proc. Natl. Acad. Sci. U.S.A. 91:1994;4489-4493.
17. Gabuzda D., Busciglio J., Yanker B.A. Inhibition of β-amyloid production by activation of protein kinase C. J. Neurochem. 61:1993;2326-2329.
18. Hung A.Y., Haass C., Nitsch R.M., Qiu W.Q., Citron M., Wurtman R.J., Growdon J.H., Selkoe D.J. Activation of protein kinase C inhibits cellular production of the amyloid β-protein. J. Biol. Chem. 268:1993;22959-22962.
19. Jacobsen J.S., Spruyt M.A., Brown A.M., Sahasrabudhe S.R., Blume A.J., Vitek M.P., Muenkel H.A., Sonnenberg-Reines J. The release of Alzheimer's disease β amyloid peptide is reduced by phorbol treatment. J. Biol. Chem. 269:1994;8376-8382.
20. Citron M., Vigo-Pelfrey C., Teplow D.B., Miller C., Schenk D., Johnston J., Winblad B., Venizelos N., Lannfelt L., Selkoe D.J. Excessive production of amyloid β-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation. Proc. Natl. Acad. Sci. U.S.A. 91:1994;11993-11997.
21. Dyrks T., Mönning U., Beyreuther K., Turner J. Amyloid precursor protein secretion and βA4 amyloid generation are not mutually exclusive. FEBS Lett. 349:1994;210-214.
22. Mullan M., Crawford F., Axelman K., Houlden H., Lilius L., Winblad B., Lannfelt L. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid. Nat. Genet. 1:1992;345-347.
23. Johnston J.A., Cowburn R.F., Norgren S., Wiehager B., Venizelos N., Winblad B., Vigo-Pelfrey C., Schenk D., Lannfelt L., O'Neill C. Increased β-amyloid release and levels of amyloid precursor protein (APP) in fibroblast cell lines from family members with the Swedish Alzheimer's disease APP670/671 mutation. FEBS Lett. 354:1994;274-278.
24. Clark R.F., Hutton M., Fuldner R.A., Froelich S., Karran E., Talbot C., et al. The structure of the Presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. Nat. Genet. 11:1995;219-222.
25. Duff K., Eckman C., Zehr C., Yu X., Prada C.-M., Perez-tur J., Hutton M., Buee L., Harigaya Y., Yager D., Morgan D., Gordon M.N., Holcomb L., Refolo L., Zenk B., Hardy J., Younkin S. Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1. Nature. 383:1996;710-713.
26. Borchelt D.R., Thinakaran G., Eckman C.B., Lee M.K., Davenport F., Ratovisky T., Prada C.M., Kim G., Seekins S., Yager D., Slunt H.H., Wang R., Seeger M., Levey A.I., Gandy S.E., Copeland N.G., Jenkins N.A., Price D.L., Younkin S.G., Sisodia S.S. Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo. Neuron. 17:1996;1005-1013.
27. Citron M., Westaway D., Xia W., Carlson G., Diehl T., Levesque G., Johnson-Wood K., Lee M., Seubert P., Davis A., Kholodenko D., Motter R., Sherrington R., Perry B., Yao H., Strome R., Lieberburg I., Rommens J., Kim S., Schenk D., Fraser P., St George-Hyslop P., Selkoe D.J. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice. Nat. Med. 3:1997;67-72.
28. Xia W., Zhang J., Kholodenko D., Citron M., Podlisny M.B., Teplow D.B., Haass C., Seubert P., Koo E.H., Selkoe D.J. Enhanced production and oligomerization of the 42-residue amyloid β-protein by Chinese hamster ovary cells stably expressing mutant presenilins. J. Biol. Chem. 272:1997;7977-7982.
29. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T.D., Hardy J., Hutton M., Kukull W., Larson E., Levy-Lahad E., Viitanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D., Younkin S. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2:1996;864-870.
30. 246) familial Alzheimer's cells. Neuroreport. 7:1995;217-220.
31. Huang H.-M., Martins R., Gandy S., Etcheberrigaray R., Ito E., Alkon D.L., Blass J., Gibson G. Use of cultured fibroblasts in elucidating the pathophysiology and diagnosis of Alzheimer's disease. Ann. N.Y. Acad. Sci. 747:1994;225-244.
32. Govoni S., Gasparini L., Racchi M., Trabucchi M. Peripheral cells as an investigational tool for Alzheimer's disease. Life Sci. 59:1996;461-468.
33. Govoni S., Bergamaschi S., Racchi M., Battaini F., Binetti G., Bianchetti A., Trabucchi M. Cytosol protein kinase C downregulation in fibroblasts from Alzheimer's disease patients. Neurology. 43:1993;2581-2586.
34. Bruel A., Cherqui G., Columelli S., Margelin D., Roudier M., Sinet P., Prieur M., Pérignon J., Delabar J. Reduced protein kinase C activity in sporadic Alzheimer's disease fibroblasts. Neurosci. Lett. 133:1991;89-92.
35. Van Huynh T., Cole G., Katzman R., Huang K., Saitoh T. Reduced protein kinase C immunoreactivity and altered protein phosphorylation in Alzheimer's disease fibroblasts. Arch. Neurol. 46:1989;1195-1199.
36. Racchi M., Bergamaschi S., Govoni S., Wetsel W.C., Bianchetti A., Binetti G., Battaini F., Trabucchi M. Characterization and distribution of protein kinase C isoforms in human skin fibroblasts. Arch. Biochem. Biophys. 314:1994;107-111.
37. Bergamaschi S., Binetti G., Govoni S., Wetsel W.C., Battaini F., Trabucchi M., Bianchetti A., Racchi M. Defective phorbol ester-stimulated secretion of β-amyloid precursor protein from Alzheimer's disease fibroblasts. Neurosci. Lett. 201:1995;1-4.
38. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;249-254.
39. Huang K.-P. The mechanism of protein kinase C activation. Trends Neurosci. 12:1989;425-432.
40. Dekker L.V., Parker P.J. Protein kinase C - a question of specificity. Trends Biochem. Sci. 19:1994;73-77.
41. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
42. Fowler C.J. The role of the phosphoinositide signalling system in the pathogenesis of sporadic Alzheimer's disease: a hypothesis. Brain Res. Rev. 25:1997;373-380.
43. Vestling M., Adem A., Racchi M., Gibson G.E., Lannfelt L., Cowburn R.F. Differential regulation of adenylyl cyclase in fibroblasts from sporadic and familial Alzheimer's disease cases with PS1 and APP mutations. Neuroreport. 8:1997;2031-2035.
44. Gibson G.E., Vestling M., Zhang H., Szolosi S., Alkon D., Lannfelt L., Gandy S., Cowburn R.F. Abnormalities in Alzheimer's disease fibroblasts bearing the APP670/671 mutation. Neurobiol. Aging. 18:1997;573-580.
45. Shanahan C., Gibson G.E., Cowburn R.F., Johnston J.A., Wiehager B., Lannfelt L., O'Neill C. G protein subunit levels in fibroblasts from familial Alzheimer's disease patients: lower levels of the high molecular weight Gsα isoform in patients with decreased β-adrenergic receptor stimulated cAMP formation. Neurosci. Lett. 232:1997;33-36.
46. Haass C., Lemere C.A., Capell A., Citron M., Seubert P., Schenk D., Lannfelt L., Selkoe D.J. The Swedish mutation causes early-onset Alzheimer's disease by β-secretase cleavage within the secretory pathway. Nat. Med. 1:1995;1291-1296.
47. De Strooper B., Saftig P., Craessaerts K., Vanderstichele H., Guhde G., Annaert W., Von Figura K., Van Leuven F. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature. 391:1998;387-390.
48. Ancolio K., Marambaud P., Dauch P., Checler F. α-Secretase-derived product of β-amyloid precursor protein is decreased by presenilin 1 mutations linked to familial Alzheimer's disease. J. Neurochem. 69:1997;2494-2499.